[AMP-activated protein kinase-alpha is involved in the autophagy and apoptosis caused by troglitazone]

Xin Jin1, Dongdong Yuan, Xiuling Chen

  • 1State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China. michelle.jinxin@163.com

Abstract

Insights

Troglitazone (TZ) activates autophagy via AMP-activated protein kinase (AMPK) signaling, preceding apoptosis. Inhibiting AMPK blocks TZ-induced autophagy and cell death, revealing AMPK

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Troglitazone (TZ) is known to induce cell death.
  • The precise mechanisms underlying TZ-induced apoptosis and autophagy remain incompletely understood.
  • AMP-activated protein kinase (AMPK) signaling pathways are implicated in cellular stress responses.

Purpose of the Study:

  • To elucidate the role of AMPK signaling in troglitazone-induced autophagy and apoptosis.
  • To investigate the temporal relationship between autophagy and apoptosis.
  • To determine if AMPK activation is a prerequisite for TZ-induced cell death.

Main Methods:

  • HeLa cells were treated with troglitazone (TZ).
  • Autophagy was assessed using markers like LC3-II and SQSTM1/p62 via western blotting.
  • Apoptosis was evaluated through caspase activation and PARP cleavage.
  • AMPK activity was modulated using siRNA interference and the inhibitor Compound C.
  • Cell viability was measured using MTS assay.

Main Results:

  • TZ treatment reduced AMPK phosphorylation and stimulated autophagy in HeLa cells.
  • TZ induced accumulation of LC3-II and degradation of SQSTM1/p62, preceding caspase activation.
  • AMPK inhibition by Compound C blocked TZ-stimulated autophagy and PARP cleavage.
  • Knockdown of autophagy-related genes or AMPK conferred resistance to TZ-induced apoptosis.

Conclusions:

  • AMPK signaling is crucial for mediating troglitazone-induced autophagy.
  • TZ-induced autophagy precedes and contributes to caspase-dependent apoptosis.
  • Targeting the AMPK-autophagy pathway may offer therapeutic strategies for TZ-related effects.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...